Rheumatology NewsReduced TNFi dose does not maintain axial spondyloarthritis improvementMarch 16, 2020Ankylosing spondylitisSpondyloarthropathies
Rheumatology NewsAdvances in ankylosing spondylitis hailed as rheumatology’s story of the yearMarch 9, 2020Ankylosing spondylitisSpondyloarthropathies
Rheumatology NewsHLA-B27 status predicts radiographic phenotype of axSpAMarch 2, 2020Ankylosing spondylitisSpondyloarthropathiesPsoriatic Arthritis
Rheumatology NewsMeta-analysis highlights safety concerns with interleukin inhibitionMarch 2, 2020Rheumatoid ArthritisMixed TopicsPediatricsAnkylosing spondylitisPsoriatic ArthritisSpondyloarthropathies
Rheumatology NewsNew guideline offers recommendations for reproductive health in patients with rheumatic diseasesMarch 2, 2020Lupus & Connective Tissue DiseasesAnkylosing spondylitisRheumatoid ArthritisPsoriatic ArthritisSpondyloarthropathies
Rheumatology NewsAnti–TNF-alpha nonresponse in axSpA predicted by socioeconomic, patient-reported factorsFebruary 19, 2020Ankylosing spondylitisSpondyloarthropathies
Rheumatology NewsIn rheumatology, biosimilars are flatlining. Why?January 27, 2020Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisPediatricsAnkylosing spondylitis
Rheumatology NewsTNFi treatment shows hint of slowing axial spondyloarthritis radiographic progressionJanuary 22, 2020Ankylosing spondylitisSpondyloarthropathies
Rheumatology NewsRepeat LTBI testing best in patients taking biologics with new risk factorsDecember 9, 2019Rheumatoid ArthritisPsoriatic ArthritisSpondyloarthropathiesAnkylosing spondylitisLupus & Connective Tissue Diseases
Rheumatology NewsFDA approves infliximab-axxq for numerous indicationsDecember 6, 2019Rheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitisPsoriatic Arthritis
Rheumatology NewsEvidence grows for early axSpA treatment, uveitis flare preventionDecember 6, 2019Ankylosing spondylitisSpondyloarthropathies
Rheumatology NewsCertolizumab may reduce uveitis flares, axSpA disease activityDecember 6, 2019Ankylosing spondylitisSpondyloarthropathies
Rheumatology NewsUpadacitinib doubles ASAS 40 response vs. placebo in ankylosing spondylitisDecember 3, 2019Ankylosing spondylitisSpondyloarthropathies
Rheumatology NewsMore studies like VERVE needed to test live vaccines in special populationsNovember 25, 2019Rheumatoid ArthritisAnkylosing spondylitisSpondyloarthropathiesPsoriatic Arthritis
Rheumatology NewsNewer IL-17 inhibitors make their case in phase 3 nonradiographic axial spondyloarthritis trialsNovember 21, 2019Ankylosing spondylitisSpondyloarthropathies
